Financial statements Apteopharm Spółka Z Ograniczoną Odpowiedzialnością

Balance sheet of Apteopharm Spółka Z Ograniczoną Odpowiedzialnością

Company age:
Age:
9 y. 4 m. 17 d.

Balance sheet data of APTEOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Year
2020
2021
2022
2023
Total assets 4 759 128,71 4 921 114,88 6 267 494,31 6 531 119,38
A. Fixed assets 400 341,06 244 900,51 174 443,79 139 434,94
B. Current assets 4 358 787,65 4 676 214,37 6 093 050,52 6 391 684,44
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 4 759 128,71 4 921 114,88 6 267 494,31 6 531 119,38
A. Equity 1 751 720,63 2 179 027,87 3 027 147,74 2 397 461,32
B. Liabilities and provisions for liabilities 3 007 408,08 2 742 087,01 3 240 346,57 4 133 658,06
I. Long-term liabilities 326 105,46 108 701,46 0,00 0,00
II. Short-term liabilities 2 223 502,34 2 608 281,79 3 210 843,13 3 990 805,11
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.